Regis Technologies, Inc.
8210 Austin Avenue
Morton Grove
Illinois
60053
U.S.A.
Phone:
847-967-6000
Fax:
847-967-1214
|
Regis Technologies, Inc., a Chicago-based CMO focused on small molecule active pharmaceutical ingredients (APIs), partners with pharmaceutical and biotechnology companies to help expedite drugs to the clinic and ultimately to the market. They offer synthesis, analytical and separation services to advance your API from initial process transfer and development, through clinical scale up and on to final validation and commercial manufacturing. Regis’ technical staff brings years of process and analytical experience to solve technical challenges inherent in all new projects. In addition, Regis also delivers added value with innovative, proprietary chiral chromatography products and services including supercritical fluid chromatography (SFC).
Regis’ outstanding compliance history, technical and project management teams, and central US location have made it the supplier of choice for emerging and mid-size pharma. In 2015, Life Science Leader identified Regis in the top 10% of pharmaceutical partners and presented President & CEO Louis Glunz IV with five CMO Leadership Awards in Quality, Reliability, Innovation, and Productivity categories.
Regis Technologies operates an FDA inspected cGMP facility with about 36,000 square feet of production space housing eight reactor suites from 25 to 500 gallons. Each suite contains a matched pair of reactors and has an air make-up system with HEPA filtered air to minimize the potential for contamination between rooms.
New for 2015, Regis’ Potent Compound Suite (PCS) is qualified and ready for projects. The PCS addition allows Regis to serve the oncology market by providing for small molecule cGMP manufacturing of potent compounds up to about one kilogram per batch.
Partner with the proven provider since 1956.
Email:
Ownership:
Private
Web Site:
Regis Technologies, Inc.
Employees:
Symbol:
|